000 | 00959 a2200301 4500 | ||
---|---|---|---|
005 | 20250512060324.0 | ||
264 | 0 | _c19870312 | |
008 | 198703s 0 0 eng d | ||
022 | _a0743-4863 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aUekama, K | |
245 | 0 | 0 |
_aCyclodextrins in drug carrier systems. _h[electronic resource] |
260 |
_bCritical reviews in therapeutic drug carrier systems _c1987 |
||
300 |
_a1-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 |
_aCyclodextrins _xmetabolism |
650 | 0 | 4 |
_aDextrins _xtherapeutic use |
650 | 0 | 4 | _aDosage Forms |
650 | 0 | 4 | _aIntestinal Absorption |
650 | 0 | 4 | _aPharmaceutical Vehicles |
650 | 0 | 4 | _aPolymers |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 |
_aStarch _xtherapeutic use |
700 | 1 | _aOtagiri, M | |
773 | 0 |
_tCritical reviews in therapeutic drug carrier systems _gvol. 3 _gno. 1 _gp. 1-40 |
|
999 |
_c3547965 _d3547965 |